HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Association of genetic polymorphisms of ER-alpha and the estradiol-synthesizing enzyme genes CYP17 and CYP19 with breast cancer risk in Chinese women.

Abstract
Estrogen plays a role in breast cancer development, and genetic polymorphisms in estrogen receptor gene ER-alpha and genes regulating estrogen biosynthesis and metabolisms are associated with the risk of breast cancer in women in western countries. Therefore, we hypothesized that SNPs in ER-alpha and other estrogen-metabolizing genes contribute to breast cancer risk in Chinese women. In this study, we genotyped polymorphisms in the regulatory regions of ER-alpha (rs3798577) and other two estrogen-metabolizing enzyme genes CYP17 (rs743572) and CYP19 (rs10046) among 300 breast cancer cases and 390 controls in a Chinese population. Crude and adjusted odds ratios (aORs) and 95% confidence intervals (CIs) were calculated by unconditional logistic regression analyses to estimate breast cancer risk associated with these polymorphisms. We found that the T allele frequency of ER-alpha was significantly higher in cases (59.8%) than controls (54.5%) (P = 0.047), but no significant difference was found in the genotype distribution. However, postmenopausal breast cancer risk was associated with the CYP17 TC genotype (aOR = 1.77, 95% CI = 1.11-2.83) compared with the TT genotype. The CYP19 variant TC + TT genotypes were associated with both overall cancer risk (TT + TC vs. TT aOR = 1.73, 95% CI = 1.13-2.65) and premenopausal cancer risk (TT + TC vs. TT aOR = 1.78, 95% CI = 1.03-3.09), particularly for ER +/PR + tumors. Furthermore, there were joint effects between CYP19 T and ER-alpha T variant genotypes (aOR = 1.67, 95% CI = 1.03-2.69 for CYP19 TC + TT vs. CC among ER-alpha T variant carriers) and between CYP19 T and CYP17 C variant genotypes (aOR = 1.77, 95% CI = 1.11-2.83 for CYP19 TC + TT vs. CC among CYP17 variant C carriers). This study provides evidence that polymorphisms CYP17 rs743572, CYP19 rs10046 and ER-alpha rs3798577 are associated with breast cancer risk among Chinese women.
AuthorsLina Zhang, Lin Gu, Biyun Qian, Xishan Hao, Wei Zhang, Qingyi Wei, Kexin Chen
JournalBreast cancer research and treatment (Breast Cancer Res Treat) Vol. 114 Issue 2 Pg. 327-38 (Mar 2009) ISSN: 1573-7217 [Electronic] Netherlands
PMID18629629 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Estrogen Receptor alpha
  • Estrogens
  • Estradiol
  • Aromatase
  • Steroid 17-alpha-Hydroxylase
Topics
  • Adult
  • Aromatase (genetics)
  • Asian People (genetics)
  • Base Sequence
  • Breast Neoplasms (genetics, pathology)
  • Carcinoma, Ductal, Breast (genetics, secondary)
  • Carcinoma, Lobular (genetics, secondary)
  • Carcinoma, Medullary (genetics, secondary)
  • Case-Control Studies
  • Estradiol (pharmacology)
  • Estrogen Receptor alpha (genetics)
  • Estrogens (pharmacology)
  • Female
  • Genotype
  • Humans
  • Middle Aged
  • Molecular Sequence Data
  • Polymorphism, Genetic (genetics)
  • Risk Factors
  • Steroid 17-alpha-Hydroxylase (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: